The Board of Directors and Management of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Audit ...
BEIJING, Aug 28 (Reuters) - Sinovac Biotech Ltd's (SVA.O), opens new tab coronavirus vaccine candidate CoronaVac was approved for emergency use as part of a programme in China to vaccinate high-risk ...
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced a transaction in which Advantech ...
The Hong Kong government will cease operations of its Covid-19 vaccine indemnity fund later this month, ending a program that ...
SERRANA, Brazil, Feb 17 (Reuters) - The COVID-19 vaccine developed by China’s Sinovac Biotech (SVA.O), opens new tab is effective against the UK and South African variants, the vaccine's Brazilian ...
BEIJING--(BUSINESS WIRE)--SINOVAC Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today the publication of two papers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback